Poxel Raises $17M in Series B

Biopharma startup Poxel SA has closed on €13 million ($17 million) in a Series B round led by Edmond de Rothschild Investment Partners. Existing investors InnoBio and Omnes Capital also participated. The company is based in Lyon, France.

North AmericaUSBriefs